29 results
424B3
CELU
Celularity Inc - Ordinary Shares
2 Jun 23
Prospectus supplement
5:00pm
in our workforce, discontinue our commercialization efforts for our biomaterials products as well as other clinical trial programs, liquidate all … reprioritization of efforts which resulted in a reduction of approximately one-third of our workforce as of March 2023.
Our Celularity IMPACT platform
424B5
vflzbbs01fi2e9l0 if
6 Apr 23
Prospectus supplement for primary offering
9:03pm
424B5
9cmt 3tzj
28 Jul 23
Prospectus supplement for primary offering
4:24pm
DRS/A
z4j1lr
28 Mar 19
Draft registration statement (amended)
12:00am
S-1
cd2g4
26 Apr 19
IPO registration
4:23pm
DRS
ryg82
5 Nov 18
Draft registration statement
12:00am
424B4
m7rlgr4
21 May 19
Prospectus supplement with pricing info
2:26pm
10-K
km8tm
24 Mar 20
Annual report
12:00am
424B3
hbsmd8
1 Jun 22
Prospectus supplement
4:06pm
424B3
cl4szpjhve f9qsx8p
3 May 22
Prospectus supplement
4:06pm
S-4
opps 2g0cy1t7sfv5t
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm